Visceral fat is a strong predictor of insulin resistance regardless of cardiorespiratory fitness in non-diabetic people

Journal of Nutritional Science and Vitaminology

Volumn 56, Issue 2, 2010, Pages 109-116

  Usui, Chiyoko ^a   Asaka, Meiko ^a   Kawano, Hiroshi ^a   Aoyama, Tomoko ^a   Ishijima, Toshimichi ^a   Sakamoto, Shizuo ^a   Higuchi, Mitsuru ^a  

^a WASEDA UNIVERSITY   (Japan)

Author keywords

Cardiorespiratory fitness; Insulin resistance; Non diabetic people; Subcutaneous fat; Visceral fat

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETER; BODY COMPOSITION; CARDIORESPIRATORY FITNESS; DIABETIC PATIENT; FEMALE; FITNESS; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PREDICTION; SUBCUTANEOUS FAT;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY COMPOSITION; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; DIABETES MELLITUS; EXERCISE TEST; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PHYSICAL FITNESS; RESPIRATORY PHYSIOLOGICAL PHENOMENA;

EID: 77954289028     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.56.109     Document Type: Article

References (21)

1. Lee ET, Keen H, Bennett PH, Fuller JH, Lu M, WHO Multinational Study Group. 2001. Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity. Diabetologia 44 (Suppl 2): S3-S13.
2. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Nomiyama K, Ohmori S, Yoshitake T, Shinkawa A, Hasuo Y, Fujishima M. 1994. The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study. Diabetologia 37: 897-904.
3. Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B, Iwamoto Y, Tajima N; International Diabetes Epidemiology Group; DECODA Study Group. 2000. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 43: 1470-1475.
4. Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, Groop LC. 2000. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 49: 975-980.
5. DeFronzo RA. 1992. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35: 389-397.
6. Racette SB, Evans EM, Weiss EP, Hagberg JM, Holloszy JO. 2006. Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50-95 year olds. Diabetes Care 29: 673-678.
7. Nagano M, Kai Y, Zou B, Hatayama T, Suwa M, Sasaki H, Kumagai S. 2004. The contribution of cardiorespiratory fitness and visceral fat to risk factors in Japanese patients with impaired glucose tolerance and type 2 diabetes mellitus. Metabolism 53: 644-649.
8. Ministry of Health, Labour and Welfare of Japan. 2006. Exercise and Physical Activity Reference Quantity for Health Promotion 2006 (EPARQ2006) -Physical Activity, Exercise, and Physical Fitness. General Affairs Division, Health Service Bureau, Ministry of Health, Labour and Welfare of Japan, Tokyo (in Japanese).
9. Pollock ML, Foster C, Knapp D, Rod JL, Schmidt DH. 1987. Effect of age and training on aerobic capacity and body composition of master athletes. J Appl Physiol 62: 725-731.
10. Kohrt WM, Kirwan JP, Staten MA, Bourey RE, King DS, Holloszy JO. 1993. Insulin resistance in aging is related to abdominal obesity. Diabetes 42: 273-281.
11. Taniguchi A, Nakai Y, Sakai M, Yoshii S, Hamanaka D, Hatae Y, Kawata M, Yamanouchi K, Okumura T, Doi K, Tokuyama K, Nagasaka S, Fukushima M. 2002. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism 51: 544-548.
12. Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y, Matsubara K. 1997. Analysis of an expression profile of genes in the human adipose tissue. Gene 190: 227-235.
13. Ronti R, Lupattelli G, Mannarino E. 2006. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64: 355-365.
14. Hu E, Liang P, Spiegelman BM. 1996. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703.
15. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
16. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ. 2002. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87: 5662-5667.
17. Lin E, Phillips LS, Ziegler TR, Schmotzer B, Wu K, Gu LH, Khaitan L, Lynch SA, Torres WE, Smith CD, Gletsu-Miller N. 2007. Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes 56: 735-742.
18. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
19. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, Ueyama Y, Froguel P, Kimura S, Nagai R, Kadowaki T. 2003. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278: 2461-2468.
20. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. 2006. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.